Although substance abuse treatment programs are important contact points for providing health services for hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, availability of services in these programs has not been well characterized. This article in Journal of Substance Abuse Treatment, by Edmund Bini, Steven Allan Kritz, Lawrence Brown Jr., James Robinson, Pacific Northwest Node researcher Donald Calsyn, and colleagues, reports on a protocol CTN-0012 survey evaluating the spectrum of HBV and HCV services offered by substance abuse treatment programs within the National Drug Abuse Treatment Clinical Trials Network (CTN).
Despite the importance of substance abuse in sustaining the hepatitis epidemics, the surveys found that few programs offer comprehensive HBV and HCV testing or HCV health care services. Because substance abuse treatment programs are an important point of contact to provide risk-reduction counseling, testing, and treatment for these infections, these identified shortcomings provide opportunities for public health intervention.
Citation: Bini EJ, Kritz SA, Brown LS Jr, et al. Hepatitis B Virus and Hepatitis C Virus Services Offered by Substance Abuse Treatment Programs in the United States. Journal of Substance Abuse Treatment 2011 (in press).